Shrewsbury, MA, United States of America

Lakshmipathi Pandarinathan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Northeastern University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lakshmipathi Pandarinathan. Retrieved from https://idiyas.com/inventor/lakshmipathi-pandarinathan-mtd9xdda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lakshmipathi Pandarinathan: Innovator in Cannabinoid Modulation

Introduction

Lakshmipathi Pandarinathan is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of cannabinoid research through his innovative work.

Latest Patents

Pandarinathan holds a patent for "Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors." This patent discloses compounds and compositions that inhibit the action of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL). It also outlines methods for modulating cannabinoid receptors and treating various disorders related to this modulation. He has 1 patent to his name.

Career Highlights

He is currently associated with Northeastern University, where he continues to advance research in cannabinoid modulation. His work has implications for various therapeutic applications.

Collaborations

Pandarinathan has collaborated with esteemed colleagues, including Alexandros Makriyannis and Nikolai M Zvonok, to further enhance the impact of his research.

Conclusion

Lakshmipathi Pandarinathan's innovative contributions to cannabinoid research highlight his role as a key inventor in this evolving field. His work continues to pave the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…